FDA Inspection
Fenwal International, Inc.Fenwal International, Inc. – FDA Inspection, Sep 24, 2022
Record Details
This FDA Inspection record concerns Fenwal International, Inc., with an inspection on September 24, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Fenwal International, Inc.
- Inspection Date
- September 24, 2022
- Product Type
- Biologics
View Company Profile
ID · 4cb7c0d2-f2b5-4730-afce-120b0a4edae5
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1180297
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Fenwal International, Inc.
11| Date | Classification | Office | Project area |
|---|---|---|---|
| February 5, 2026 | Not classified | San Juan District Office | Blood and Blood Products |
| September 18, 2024 | VAI | San Juan District Office | Blood and Blood Products |
| September 24, 2021 | OAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 26, 2019 | OAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 22, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Fenwal International, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.